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ABSTRACT 
Current pharmacological treatments for lung cancer show very poor clinical outcomes, 
therefore, the development of novel anticancer agents with different mechanisms of action 
is urgently needed. Cancer cells have a reversed pH gradient compared to normal cells, 
which favors cancer progression by promoting proliferation, metabolic adaptation and 
evasion of apoptosis. In this regard, the use of ionophores to modulate intracellular pH 
appears as a promising new therapeutic strategy. Indeed, there is a growing body of 
evidence supporting ionophores as a novel antitumor drugs. Despite this, little is known 
about the implications of pH deregulation and homeostasis imbalance triggered by 
ionophores at the cellular level. In this work, we deeply analyze for the first time the 
anticancer effects of tambjamine analogues, a group of highly effective anion selective 
ionophores, at the cellular and molecular level. First, their effects on cell viability were 
determined in several lung cancer cell lines and patient-derived cancer stem cells, 
demonstrating their potent cytotoxic effects. Then, we have characterized the induced 
lysosomal deacidification, as well as, the massive cytoplasmic vacuolization observed after 
treatment with these compounds, which is consistent with mitochondrial swelling. Finally, 
the activation of several proteins involved in stress response, autophagy and apoptosis was 
also detected, although necrosis was the main mechanism of  cell death induced.  
Altogether, these evidences suggest that tambjamine analogues provoke an imbalance in 
cellular ion homeostasis that triggers mitochondrial dysfunction and lysosomal 
deacidification leading to a potent cytotoxic effect through necrosis in lung cancer cell lines 
and cancer stem cells. 
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1. Introduction  
Correct ion exchange through cellular membranes is an essential process for maintaining 
osmotic balance and intracellular pH (pHi) [1], which are key parameters controlling many 
biological processes. In fact, variations in cellular concentrations of certain ions coordinate 
the signals that converge on cell cycle checkpoints [2], regulating the proliferative capacity of 
cells and their differentiation. Similarly, the triggering of the apoptotic programmed cell 
death also depends on ion fluxes mediated by cellular ion channels [3]. Therefore, when 
cellular pH is not preserved at a favourable level, different pathologies may appear, as it is 
the case of cancer. Cancer cells undergo a pH deregulation during the process of 
carcinogenesis, resulting in the acidification of the extracellular pH (pHe) and the 
alkalinisation of the pHi. This adaptive reversed pH gradient is decisive for survival and 
propagation of tumours, promotes metabolic adaptation, evasion of apoptosis and facilitates 
the metastatic dissemination of tumour cells. Consequently, pH is recently being considered 
as another hallmark of cancer [4]. 
Among different cancers, lung cancer remains a major public health problem since it is the 
leading cause of mortality related to this disease, accounting for more than 1.5 million 
deaths in 2012 [5]. Early diagnosis and advances in first-line treatments are not entirely 
effective in reducing this high mortality since conventional treatments have limited success. 
Therefore, the identification of novel anticancer compounds focused on different 
mechanisms of action is eagerly needed [6, 7]. 
Based on the specific altered pH of cancer cells, modulation of intracellular pH has recently 
been proposed as a new therapeutic strategy against cancer. In this regard, a diverse group 
of anionophores, lipid soluble compounds that facilitate the transport of anions across cell 
membranes, have recently emerged as promising anticancer compounds [8, 9]. Indeed, 
prodigiosin, a tripyrrolic natural product with anticancer properties, represents one of the 
first described anionophores [10-13]. It has been reported that its biological activity is partly 
due to its ability to deacidify acidic compartments within cells, which may cause a drop in 
pHi, and therefore the onset of apoptosis in cancer cells [9, 11, 14]. Emulating that 
characteristic, different anionophores have been designed and evaluated [15]. We focused 
our attention on the bioactive marine alkaloids tambjamines, other class of natural 
anionophores which have shown interesting cytotoxic [16, 17]. We have recently 
synthesized novel synthetic tambjamine analogues bearing aromatic substituents in the 
enamine moiety, as well as explored different substitution patterns on characteristic alkoxy 
group of the central pyrrole ring. These compounds proved to be very efficient anion 
exchangers in liposome models, promoting both chloride and bicarbonate transport [18-20]. 
As a result of this anionophoric activity, compounds bearing 4-alkoxy-2,2´-bipyrrole moieties 
have shown to possess interesting anticancer activities in a wide panel of cancer cell lines 
[19]. Moreover, a different type of tambjamine analogues, in which the characteristic 2,2`-
bipyrrole unit is replaced by a 2-pyrrolylindole, have recently shown the ability to 
hyperpolarize the cellular membrane as well as differentiate and induce cell death in lung 
cancer stem cells [20], which are promising properties for their potential use in cancer 
therapy.  
Despite the identification of this class of anion selective ionophores as novel potential 
anticancer drugs, very little is known about the effects at the cellular level of the facilitated 
anion transport and the implications of unbalanced homeostasis and pH deregulation in the 
cytotoxicity exhibited by anionophores. In the present work, we analyse in detail for the first 
time the cellular and molecular mechanisms of action that lead to the cell death triggered by 
these potent anionophores in several lung cancer cell lines and cancer stem cells (CSC). 
2. Materials and Methods 
2.1. Compounds synthesis 
Tambjamine analogues (Figure 1a) were synthesized as previously reported [19]. Drugs were 
dissolved at 10 mM in DMSO and stored at -20C. Subsequent dilutions for biological assays 
were made in culture medium. 
2.2. Cell lines and culture conditions 
Human lung cancer cell lines A549 (adenocarcinoma), DMS53 (small cell carcinoma), H460 
(large cell carcinoma) and SW900 (squamous carcinoma) were obtained from the American 
Type Culture Collection (ATCC, Manassas VA), and maintained in DMEM (A549) or RPMI 
media (Biological Industries, Beit Haemek, Israel). All media were supplemented with 100 
U/mL penicillin, 100 µg/mL streptomycin, and 2 mM L-glutamine, all from Biological 
Industries and 10% foetal bovine serum (FBS; Gibco, NY, USA). Cancer stem cells were 
obtained from resected patient tumour samples or isolated from cancer cell lines and 
characterized through evaluation of stem cell surface markers (CD166, CD44, CD90, CD133 
and EpCAM) by flow cytometry. Moreover, tumorigenic properties of tumour spheres were 
assessed through subcutaneous transplantation in NOD.CB17-Prkdcscid/NcrCrl mice (Jackson 
Laboratories) and tumor growth curves were monitored. For detailed procedures and results 
see supplementary information in reference [20]. CSC were cultured as a cell suspension in 
RPMI media supplemented with 50 μg/mL EGF, 20 μg/mL bFGF, 1X ITS, 0.4% BSA and 2% B27 
(Gibco, Paisley, UK). Cells at passage 10-25 were grown at 37C under a 5% CO2 atmosphere.  
2.3. Cell viability assay 
Cell viability was determined by the MTT assay [21]. Cells (1 × 105 cells/mL) were seeded in 
96-well microtiter plates and incubated for 24 h to allow cells to attach. Afterwards, they 
were treated for 24 h with 10 µM of each compound for single point experiments and dose-
response curves were performed ranging from 0.78 to 100 µM to calculate the inhibitory 
concentrations of 25%, 50% and 75% of cell population (IC25, IC50, and IC75 values). Cisplatin 
and DMSO were used as positive and negative controls, respectively. In the case of positive 
control, concentrations ranging from 1.56 to 200 µM were tested. For inhibition assays, the 
apoptotic inhibitor Z-VAD-FMK (10 µM) or the autophagic inhibitor 3-MA (5 mM) were 
added 30 min prior compound 2 addition. After 24 h, 10 µM of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide diluted in 1X PBS (MTT, Sigma-Aldrich) was added to each 
well for an additional 4 h. The medium was removed and the MTT formazan precipitate was 
dissolved in 100 µL of DMSO. Absorbance was read on a Multiskan multiwell plate reader 
(Thermo Fisher Scientific Inc., Waltham, MA, USA) at 570 nm. For each condition, at least 
three independent experiments were performed in triplicate. Cell viability was expressed as 
a percentage of control cells, and data are shown as the mean value ± S.D. The IC25, IC50 and 
IC75 values were calculated with GraphPad Prism 5 software. 
For single-point cell viability assays in monolayer cells (passage 10-20) and spheres-forming 
cells (passage 1-2), they were plated at the desired density (1-2 x 103 or 2-3.5 x 103, 
respectively) in 200 μL per well in 96-well plates. One day (24 h) after seeding, compound 2 
was added in three replicates at 10 μM for each cell line or patient’s derived cultures. 
Patient samples acquisition protocol and informed consent were approved by the local 
ethics committee. Cell viability was measured after 24 h, using the CellTiter 96® AQueous 
One Solution Cell Proliferation Assay (Promega, Madison, WI, USA) and following the 
manufacturer’s instructions. Absorbance at 490 nm was detected using a VICTOR3 Multilabel 
Plate Reader (Perkin Elmer-Cetus, Norwalk, CT). Cell viability was normalized to the 
respective control cells and presented as a percentage of them. For each condition, three 
independent experiments were performed and mean ± SD is shown. 
2.4. ISE transport assays  
A chloroform solution (20 mg/mL) of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) (Sigma-Aldrich, St Louis, MO, USA) was evaporated in vacuo using a rotary 
evaporator and the resulting lipid film was dried under vacuum for at least 2 h. After that, it 
was rehydrated by addition of a sodium chloride solution (489 mM NaCl and 5 mM 
phosphate buffer, pH 7.2 or 451 mM NaCl and 20 mM phosphate buffer, pH 7.2) followed by 
careful vortexing. The obtained lipid suspension was subjected to nine freeze-thaw cycles 
and twenty-nine extrusions through a 200 nm polycarbonate Nucleopore membrane using a 
LiposoFastBasic extruder (Avestin Inc., Ottawa, Canada). In order to remove the 
unencapsulated chloride, the obtained vesicles were dialyzed against a NaNO3 solution (489 
mM NaNO3 and 5 mM phosphate buffer, pH 7.2) or a Na2SO4 solution (150 mM Na2SO4 and 
20 mM phosphate buffer, pH 7.2), respectively. For the NO3
-/Cl- assays, vesicles prepared as 
described above (rehydrated with 489 mM NaCl), were suspended in a solution 489 mM 
NaNO3 and 5 mM phosphate buffer, pH 7.2 to a final lipid concentration of 0.5 mM in a total 
volume of 5 mL. Using a chloride selective electrode (CRISON 96 52 C I.S.E. electrode) the 
chloride efflux was monitored over time. After 60 s, an aliquot of the transmembrane anion 
carrier in DMSO was added (the amount of DMSO was always less than 20 µL in order to 
avoid influence of the solvent molecules in the assay). After five minutes (t=360 s), a pulse of 
detergent was added (Triton X-100 10% dispersion in water, 20 μL), thus vesicles were lysed. 
The obtained final reading was considered as the 100% of the chloride encapsulated and 
used as such. For (HCO3
-/Cl-) assays, the vesicles were rehydrated with 451 mM NaCl and 
suspended in the Na2SO4 solution. Again, the final lipid concentration in each experiment 
was 0.5 mM and the total volume in each experiment 5 mL. A volume of the carrier molecule 
was added at the beginning of the experiment (t=0 s). A minute later (t=60 s), an aliquot of 
NaHCO3 (in 150 mM Na2SO4 buffered to pH 7.2 with 20 mM sodium phosphate salts) was 
added for a final concentration of 40 mM. The chloride efflux was measured during 5 min 
and then the detergent was added (t=360 s). The data were used as described previously. 
2.5. Acridine Orange staining  
A549 cells (1 x 105 cells/well) grown in a 12-well plate with cover slips for 24 h were treated 
with or without the IC50 value of the studied compounds for 1 h (DMSO was added in control 
cells). Afterwards, cells were washed twice with 1X PBS and stained with 5 µg/mL acridine 
orange (AO) solution for 30 min at room temperature. Finally, they were washed three times 
with 1X PBS/10% FBS and fluorescence was immediately examined in a NIKON eclipse E800 
microscope (filter 330/380 nm). Three independent experiments were conducted and 
representative images are shown. 
2.6. Phase contrast microscopy  
For cytoplasmic vacuolization observation, A549 cells (1 × 105 cells/mL) were seeded in a 6-
well plate and allowed to grow for 24 h, subsequently cells were treated with the IC75 values 
of each compound during 6 h and images were observed under inverted phase contrast 
microscope (Axio Observer Z1). For cell monitoring, A549 cells (1 × 105 cells/mL) were 
seeded in 96-well microtiter plates and incubated for 24 h to allow cells to attach. 
Afterwards, they were treated for 24 h with 10 µM of each compound. Then, images were 
captured following a time course from 0 (before adding drug) to 24 h with a Leica inverted 
phase-contrast microscope DMIRBE equipped with digital capture software (Leica 
Microsystems, Wetzlar, Germany).  
2.7. Immunofluorescence microscopy 
A549 cells (2 x 105 cells/mL) were cultured in a 12-well plate containing glass coverslips and 
were incubated with the IC75 of the studied compounds for 6 h. Cells were then washed 
twice with 1X PBS and fixed with 4% paraformaldehyde for 20 min. Fixed cells were 
permeabilized with 0.2% Triton X-100 and then blocked with 1% BSA in 1X PBS for 1 h. Cells 
were incubated overnight at 4C with anti-LC3 (1:500 dilution, Cat#PM036) from MBL 
International Corporation or anti-TOMM20 (1:200 dilution, Cat#612278) from BD 
Biosciences (San Jose, CA, USA). In case of using anti-EEA1 (1:1000 dilution, Cat#ab2900) and 
anti-LAMP1 (1:1000 dilution, Cat#ab24170) both from Abcam (Cambridge, MA, USA) cells 
were permeabilized with 0.2% Saponin, for 15 min, and then blocked with 0.2% gelatin-20% 
normal goat serum in 1X PBS for 1 h at room temperature. 
Cells were then washed with 1X PBS and incubated with Alexa Fluor 555-conjugated donkey 
anti-mouse (Cat#A31570, Molecular Probes, Eugene, OR, USA) or Alexa Fluor 555-conjugated 
donkey anti-rabbit (Cat#A31572, Molecular Probes) at 1:400 dilution for 1 h at room 
temperature. At the same time, the nuclear marker TOPRO-3 iodide (1:400, Cat#T3605, 
Molecular Probes) was added. Afterwards, coverslips were washed with 1X PBS and were 
placed on the slides using mowiol (Sigma-Aldrich). The immunofluorescence images were 
captured using a Leica TCS-SL filter-free spectral confocal microscope (Leica Microsystems). 
Representative images from three independent experiments are shown. 
2.8. mCherry-Mito7 stable transfection in A549 cells 
A549 cells (3 x 105 cells/mL) were seeded in 60 mm plates and allowed to grow up to 80% 
confluence. Before transfection, growth media was replaced by Optimem media without FBS 
(Gibco) and 8 µg of plasmid DNA (mCherry-Mito-7 was a gift from Michael Davidson 
(Addgene plasmid # 55102) [22] was transfected using 20 µL of lipofectamine reagent 
(Invitrogen, Carlsbad, CA, USA) per condition. After 5 h of transfection, the media was 
replaced by complete media. Stable selection was performed by adding G418 (Calbiochem, 
La Jolla, CA) to the media at 800 µg/mL final concentration 2 days after the transfection. 
After 3 weeks, the brightest cell population was selected by cell sorting using a Moflo Astrios 
XPD Cell Sorter (Beckman Coulter, Miami, FL, USA). When a stable mCherry-Mito7 
overexpressing A549 cell line was established, cells were seeded in a µ-Slide chambered 
coverslip (Ibidi), and allowed them to attach and grow during 72 h. Afterwards, cells were 
exposed to IC75 of the studied compounds and a far-red nuclear counterstain, DRAQ5 
(Abcam) was applied at a 1:5,000 dilution. The images were captured every 20 min for 3 h 
using a Leica TCS-SL filter-free spectral confocal microscope (Leica Microsystems). 
Representative images from three independent experiments are shown. 
2.9. Transmission electron microscopy 
A549 cells (2 x 105 cells/mL) grown in 100 mm plates and were incubated with the IC75 of the 
studied compounds for 6 h. Cells were fixed in a solution containing 2% paraformaldehyde, 
2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2) at room temperature for 1 h and 
then collected as cell pellets. Pellets were kept in a post-fixed solution containing 1% 
osmium tetroxide, 0.8% potassium ferrocyanide in 0.1M phosphate buffer (pH 7.2) at 4°C. 
After that, cells were dehydrated in graded acetone, embedded in Spurr’s resin and cured at 
60°C for 48 h. Semithin sections (1 μm) were cut with a glass knife, mounted on slides, 
stained with 1% methylene blue and viewed using a light microscope to select the region of 
interest. Ultrathin sections (60-70 nm) were cut using a diamond knife, mounted on 200 
mesh copper grids and double-stained with 2% aqueous uranyl acetate (for 30 min) and 
Reynold’s lead citrate (for 10 min). Specimens were examined in a transmission electron 
microscope Jeol 1010 (Jeol, Tokyo, Japan) and digital images were acquired using a Gatan 
Orius SC1000 CCD Digital Camera. Two independent experiments were performed and 
photographs were taken from at least three different semithin sections from each 
experiment. 
2.10. Mitotracker staining 
A549 cells (1 x 104 cells/well) were seeded in 8-well sterile μ-Slide (chambered coverslip) 
(Ibidi, Martinsried, Germany), and allowed to attach and grow during 72 h. Then, cells were 
preincubated with MitoTracker Red CMXRox 500 nM during 1 h, washed with 1X PBS and 
exposed to IC75 value of compound 2 for 3 h. Immunofluorescence images were captured 
using a Leica TCS-SL filter-free spectral confocal microscope (Leica Microsystems). 
Representative images from three independent experiments are shown. 
2.11. Immunoblot analysis 
A549 cells (1 x 105 cells/mL) were seeded and allowed to grow for 24 h. Afterwards, they 
were exposed to compounds (IC25, IC50 and IC75 values) for 24 or 48 h. Total protein extracts 
were obtained from cells by the addition of lysis buffer (0.1% SDS, 1% NP-40, 0.5 % sodium 
deoxycholate, 50 mM NaF, 40 mM β-glycerophosphate, 200 μM sodium orthovanadate, 1 
mM phenylmethylsulfonyl fluoride, serine and cysteine protease inhibitor cocktail (Roche 
Mannheim, Germany) in 1X PBS). Protein concentration was determined by BCA protein 
assay (Pierce, Rockford, IL, USA) using bovine serum albumin (BSA) as a standard. After that, 
40 μg of protein extracts were separated by 8-15% SDS-polyacrylamide gel electrophoresis 
and transferred to Immobilon-P membranes (Millipore, Bedford, MA, USA). Membranes 
were blocked in 5% dry milk or 5% BSA, both diluted in 1X TBS–Tween (50 mM Tris–HCl pH 
7.5, 150 mM NaCl, 0.1% Tween 20) for 1 h and then incubated overnight with primary 
antibodies, according to the manufacturer’s instructions. Antibodies were obtained from the 
following sources: anti-caspase 3 (Cat#9662), anti-caspase 9 (Cat#9502), anti-PARP 
(Cat#9542), anti-phospho-p38 MAPK (Thr180/Tyr182, Cat#4511), anti-p38 MAPK (Cat#8690), 
from Cell Signaling Technology (Beverly, MA, USA); anti-LC3 (Cat#PM036) and anti-
p62/SQSTM1 (Cat#PM045) both from MBL International Corporation (Woburn, MA, USA); 
anti-actin (I-19, Cat#sc-1616) from Santa Cruz Biotechnology (Santa Cruz, CA) and anti-
vinculin (Cat#V-4505) from Sigma-Aldrich. Antibody binding was detected with goat anti-
mouse IgG-HRP (Cat#sc-2005), goat anti-rabbit IgG-HRP (Cat#sc-2004) and donkey anti-goat 
IgG-HRP (Cat#sc-2020) all from Santa Cruz Biotechnology, and the ECL detection kit 
(Amersham, Buckinghamshire, UK). Actin or vinculin were used as gel loading controls. 
Results shown are representative of Western blot data obtained from at least three 
independent experiments with similar observations. Images were captured on an Image 
Quant LAS 500 (GE Healthcare Little Chalfont, UK) and band densitometries were retrieved 
using the software ImageJ version 1.43u software (National Institutes of Health, Bethesda, 
Maryland, USA).  
2.12. Statistical analyses  
Results are expressed as the mean ± SEM of at least three independent experiments. One-
way ANOVA analyses were carried out with the Statgraphics centurion statistical package 
and post-hoc Tukey analyses were performed. Statistically significant differences, p<0.05 and 
p<0.01, are represented by * and **, respectively. 
 
3. Results  
3.1. Compounds cytotoxic effects on cancer cell lines and cancer stem cells  
The effect on cell viability of several tambjamine analogues (Figure 1a), selected from a 
previous screening [19], was evaluated in different lung cancer cell lines representative of 
the four major histological subtypes (A549, adenocarcinoma; SW900, squamous cell 
carcinoma; H460, large cell carcinoma; DMS53, small-cell carcinoma) (Figure 1b). Cell 
viability was measured by the MTT assay and a significant decrease (more than 50%) was 
observed after 24 h with 10 µM of all the tested compounds. From these experiments two 
derivatives (compounds 2 and 7) were selected as the most potent compounds. Then, dose-
response experiments were conducted in A549 cells and compared to a positive control, 
cisplatin as a current chemotherapeutic treatment in lung cancer. The IC50 values obtained 
for compound 2 and 7 were 3.38 ± 0.98 and 1.67 ± 0.29 µM and IC75 values were 4.72 ± 0.76 
and 3.57 ± 0.49 µM, respectively; while IC50 value for cisplatin (CDDP) was more than 200 
µM (Figure 1c).  
Cell viability after treatment with the most potent compound, tambjamine 2, was also 
evaluated in cancer stem cells (CSC) derived from patients or isolated from cancer cell lines 
(Figure 1d). The derived tumour spheres were deeply characterized, showing enrichment in 
stem cell surface markers as well as great tumorigenic properties in scid mice 
transplantation experiments (see supplementary information reference [20]. Our results 
show a significant decrease in cell viability, either in CSC derived from cell lines (A549 and 
SW900) or derived from tumour patient samples (FIS302 and FIS303). 
3.2. Tambjamine derivatives are effective anion transporters 
The activity as transmembrane anion carriers of the two most cytotoxic compounds, 2 and 7, 
was assayed in model POPC liposomes. Chloride loaded liposomes were suspended in an 
isotonic chloride free medium, and chloride efflux facilitated by these compounds was 
monitored using a chloride selective electrode. At the end of the experiments, vesicles were 
lysed by the addition of detergent and the final electrode reading considered as 100% 
chloride release. Quantification of the transport activity was carried out by repeating the 
experiments using several concentrations of the studied compounds and performing hill 
analyses of the results (Figure 2a and b). The resulting EC50 value represents the amount of 
compound needed to release 50% of the encapsulated chloride in the time scale of the 
experiments (300 s). The EC50 values obtained for 2 and 7 were 50 nM and 60 nM 
respectively in the assay involving NaNO3 as external solution and 240 nM and 880 nM 
respectively in the assay involving NaHCO3 as external solution. The impact on the EC50 
values of the external anion is consistent with an exchange mechanism in which chloride 
efflux from the interior of the vesicle is accompanied by influx of the external anion, thus 
precluding the formation of an electrochemical gradient. The relative higher lipophilicity of 
nitrate compared to bicarbonate makes this later anion more difficult to extract into the 
membrane hydrophobic core and hence the higher EC50 observed. This transport mechanism 
has been studied by us in detail and the result demonstrate that 2 and 7 are very potent 
anionophores promoting effective transmembrane anion transport in vesicles at low 
loadings [19].  
3.3. Lysosomal pH deregulation 
Lysosomal pH modifications in A549 cells were analysed using acridine orange staining [23]. 
This dye accumulates into acidic organelles, like lysosomes or late endosomes, and emits 
orange fluorescence as a result of its protonation under these acidic pH conditions, whilst it 
emits green fluorescence in other parts of the cell, as observed in control cells (Figure 2c). 
When A549 cells were treated with IC50 values of compounds 2 or 7 for 1 h, the orange 
fluorescence in the vesicle compartments disappeared, indicating an increase in the pH of 
these organelles. This result is in agreement with the ionophoric activity of these compounds 
facilitating the transmembrane transport of anions such as bicarbonate across cellular 
membranes and this pH alteration should result in lysosomal dysfunction. 
3.4. Cytoplasmic vacuolization induced by tambjamine analogues 
After treatment with compounds 2 or 7, massive cytoplasmic vacuolization was observed by 
phase contrast microscopy after 6 h exposure with their IC75 values (Figure 3a). To better 
understand this phenomenon, cells were monitored during 24 h after 10 µM treatment with 
each compound (Figure 3b). Cytoplasmic vacuolization was observed as soon as 3 h of 
compounds addition and was maintained up to 24 h. In the case of compound 2, cell death 
due to cellular swelling and/or burst was observed within the 24 h period. This is indicative 
of necrotic cell death reflecting the potent cytotoxic activity of this compound. 
In order to determine which cellular organelle was undergoing this vacuolization process, 
several subcellular markers were used for immunofluorescence detection (Figures 4 and 5). 
First of all, the autophagosomal marker LC3 was evaluated and, although a high increase on 
protein levels was observed, it did not colocalize with the vacuoles (Figure 4a). Then, the 
lysosomal marker LAMP1 and the early endosomal marker EEA1 were used and different 
protein localization was observed in treated cells, but again neither colocalized with the 
vacuolated organelle (Figure 4b and 4c). Moreover, the hydrophilic polysaccharide dextran-
red was administered to treated cells to monitor macro/pinocytosis, but we did not obtain 
vesicle staining (data not shown). Finally, a mitochondrial protein called TOMM20 was 
employed and proved to stain the membranes of the vacuoles, indicating that mitochondrial 
swelling was occurring after compound treatment (Figure 5a) and ruling out vacuolization of 
autophagosomes, lysosomes or endosomes.  
3.5. Mitochondrial swelling 
To further characterize that the vacuolated organelle was mitochondria, a plasmid with the 
mitochondrial targeting sequence from subunit VIII of human cytochrome c oxidase was 
transfected into cells in order to monitor mitochondria. Control cells showed typical red 
mitochondrial staining, whereas in cells treated with compound 2, mitochondrial swelling 
was clearly observed (Figure 5b). Transmission electron micrographs were obtained from 
control and cells treated with compounds 2 or 7 to analyse these results in deep, and 
mitochondrial swelling was also observed (black arrows, Figure 5c). Moreover, many 
autophagy-related structures such as autophagosomes, autolysosomes and dense lysosomes 
are also visualized in treated cells. 
This process was also studied using MitoTracker Red CMXRos, a fluorescent dye whose 
accumulation depends on mitochondrial membrane potential [24], to track mitochondria 
(Figure 6). Control cells showed typical filamentous mitochondria, but in treated cells 
mitochondria gradually swelled to a larger size structure and finally lost fluorescence. This 
indicates that mitochondrial membrane potential is lost during the swelling process after 
compound treatment.  
3.6. Molecular cell death mechanisms  
Finally, to understand the molecular cell death mechanisms triggered by these compounds, 
cells were treated with compound 2 and several proteins involved in stress response, 
autophagy and apoptosis were analysed. Activation of p38 Mitogen-Activated Protein Kinase 
(MAPK) in A549 cells was observed in a dose-response manner (Figure 7a). This signal has 
been reported to activate apoptosis after some stresses. After 24 h of treatment with higher 
concentrations of compound 2, we were able to observe a small activation of caspase 9 and 
3, as well as PARP cleavage (Figure 7b). Likewise, no statistically significant effects in 
apoptotic markers were observed after 48 h treatment. To further analyse whether this 
apoptotic activation was involved in the cytotoxic effect induced by tambjamines, a pan-
caspase inhibitor (10 µM Z-VAD-FMK) was added before treatment with compound 2. Under 
these conditions, cell viability was not recovered (data not shown). Therefore, this result 
suggested that although apoptosis is being triggered by these tambjamine analogues, this 
process is not entirely responsible for the cytotoxic effect induced by these compounds.  
This led us to study the autophagic process after compound treatment and to investigate 
whether it was involved in the observed cytotoxicity. At very low concentrations of 
compound 2 (IC25), an impressive appearance of the lipidated LC3 form (LC3-II), indicative of 
autophagosome formation (Figure 7c), was detected. On the other hand, p62, a protein that 
is itself degraded by autophagy, was not degraded but accumulated after treatment, 
indicating a blockade of the autophagic flux. To elucidate whether autophagy was involved 
in the induced cell death, an inhibitor of autophagosomes formation (5 mM 3-MA) was 
added prior compound administration (data not shown). Cell viability was not recovered 
after 3-MA administration, suggesting that autophagosomes formation and their 
accumulation are not crucial for the cytotoxic effect induced by tambjamines. Finally, at 
higher doses and 24 h of treatment, tambjamines also provoked cytoplasmic swelling, which 
finally led to plasma membrane breakdown indicative of necrosis, as observed in the phase 
contrast images (Figure 3b) and the supplementary video.   
4. Discussion 
Diverse synthetic tambjamine analogues have recently shown potent anticancer activity in a 
panel of cancer cell lines, including human melanoma, lung carcinoma, colorectal 
adenocarcinoma and mammary adenocarcinoma cells [19, 20]. In this study, we extend the 
results obtained with those compounds bearing 4-alkoxy-2,2´-bipyrrole moieties [19] to 
several lung cancer cell lines and CSC, as well as characterize in deep for the first time the 
cellular and molecular events that are participating in the cell death induced by these potent 
compounds.  
Cell viability was significantly reduced by most of the tested compounds in all human lung 
cancer cell lines studied, and compound 2 showed to be especially potent against patient-
derived CSC. This tumour subpopulation possesses tumour-initiating and self-renewal 
capacities, and contributes to acquired chemotherapy resistance in cancer [25], thus these 
results are very promising for lung cancer treatment and the prevention of tumour 
recurrences. In this view, other anionophores such as the recently reported 2-pyrrolylindole 
tambjamine analogues or the cation selective ionophore salinomycin, also induce CSC-
specific toxicity [20, 26], indicating that the application of these kind of compounds might be 
a very promising therapy. 
Once the cells internalize these synthetic tambjamine analogues, several cellular processes 
occur, converging in the potent cytotoxic effect observed. On one hand, a huge cytoplasmic 
vacuolization was detected after compound treatment, which was due to mitochondrial 
swelling, as demonstrated by several specific markers of this organelle. Moreover, after 
significant organelle swelling, loss of mitochondrial membrane potential was induced by 
compound 2. Mitochondria in eukaryotic cells are the essential machinery to provide energy 
with an aerobic environment. It has previously been described in cells with acute cellular 
injury that mitochondrial depolarization and mitochondrial membrane permeabilization lead 
to a large amplitude swelling and cellular ATP depletion [27, 28]. Therefore, mitochondrial 
dysfunction observed after tambjamine analogues treatment may cause an energetic failure 
contributing to their cytotoxic effect. 
Autophagy is a catabolic process whereby cellular components are enclosed in double-
membrane vesicles referred to as autophagosomes, targeting them for lysosomal 
degradation. This process serves as an essential cytoprotective response to pathologic 
stresses [29]. Accumulation of defective mitochondria triggers its selective degradation, 
process known as mitochondrial autophagy or mitophagy, maintaining a healthy population 
of these organelles [30, 31]. A very significant amount of the autophagosomal marker LC3II 
protein accumulates after treatment with tambjamine analogues, even at very low 
concentrations. This indicates that the process of autophagy is being triggered by the 
treatment with these tambjamine analogues and that the induced mitochondrial damage 
may launch the process of mitophagy in order to remove damaged organelles. This 
phenomenon is frequently found as a result of mitochondrial stress, such is the case of 
treatment with the mitochondrial chain uncoupler carbonyl cyanide m-
chlorophenylhydrazone (CCCP)[32], or salinomycin, an ionophore which affects 
mitochondrial potential [33]. On the other hand, it has recently been reported that pHi 
changes modulate both autophagy and mitophagy [34], thus the changes in cellular pH 
caused by these compounds could also be contributing to trigger this pathway [20].  
The loss of the typical acridine orange fluorescence in acidic organelles after exposure to our 
compounds indicates lysosomal alkalization. This increase in lysosomal pH is consistent with 
an anion carrier activity across cellular membranes, similarly to that observed in model 
liposomes. Interestingly, it has recently been reported that obatoclax, other anionophore 
related to the prodiginine family which has been evaluated in clinical trials for different 
cancer conditions, rapidly localizes to the lysosomes and also induces lysosomal alkalization 
[35, 36]. 
Lysosomes contain many different types of hydrolytic enzymes that usually exert their 
maximal enzymatic activity at low pH [37]. Typically, an increase in lysosomal pH could 
derive from H+ leakage, a defective proton pump or lysosomal permeabilization [38]. This 
could lead to a failure in their proper functioning, resulting in blockade of autophagy [39, 
40]. After tambjamine analogues treatment, increase in the lysosomal pH derived from 
lysosomal membrane permeabilization may inactivate its hydrolytic enzymes and therefore 
it may block autophagy. This feature mainly occurs because this organelle is essential in the 
final step of the autophagic process, wherein autophagosomes fuse with lysosomes and 
subsequent protein digestion occurs [41]. The autophagic substrate, p62, also known as 
sequestosome 1 (SQSTM1), binds ubiquitinated proteins for subsequent degradation in 
lysosomes, where it is also degraded [42]. Our results show that there is no p62 degradation, 
indicating an impairment in the autophagic flux and consequent accumulation of 
unprocessed autophagosomes or autolysosomes [43]. Moreover, the autophagy inhibitor 3-
MA, which inhibits autophagy by blocking autophagosomes formation via the inhibition of 
type III Phosphatidylinositol 3-kinases, is not able to reverse the cytotoxic effect induced by 
tambjamines. Thus this autophagy might be contributing to the cytotoxic effect, but it is not 
responsible for it. Nevertheless, mitochondrial dysfunction along with a defect in autophagy 
catabolism due to lysosomal deacidification might be detrimental to tumor cells since they 
produce low rates of ATP and impaired recycling of nutrients for energy production, as well 
as an imbalance in vesicular biogenesis and turnover. This cellular stress is reflected by p38 
MAPK activation, which may initiate apoptosis [44], although again this process is not crucial 
for the observed cytotoxicity elicited by these compounds. Therefore, the imbalance in 
cellular ion homeostasis that triggers mitochondrial dysfunction and lysosomal 
deacidification may be inducing cell death by necrosis after tambjamine analogues 
treatment. In this regard, the lysosomal permeabilization induced by obatoclax in apoptosis-
resistant anaplastic thyroid cells has been demonstrated to be sufficient to induce necrosis 
in this resistant model, representing an interesting therapeutic approach [36]. 
Overall, these new tambjamine analogues show promising anticancer properties in lung 
cancer and could represent a good therapeutic option for apoptosis-resistant tumors. These 
results shed light into the cellular and molecular mechanisms resulting from the action of 
these compounds. Lysosomal and mitochondrial dysfunction led to necrosis as the main cell 
death mechanism responsible for the cytotoxicity of these compounds, which might be 
shared by other active small molecule anionophores. 
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Figure 1. Synthetic tambjamine analogues significantly decrease cell viability. (A) Chemical 
structure of synthetic tambjamine analogues. (B) MTT cell viability assay was performed 
after 24 h of treatment with synthetic tambjamine analogues at 10 µM in A549, DMS53, 
H460 and SW900 cell lines. (C) Concentrations ranging from 0.8 to 100 µM of compounds 2 
and 7 were used in dose-response curve experiments for ICs value calculation in A549 cell 
line, at the same time, in case of positive control, concentrations ranging from 1.6 to 200 µM 
of cisplatin (CDDP) were tested. (D) Cell viability was tested in adherent (Adh) and cancer 
stem cells (CSC) derived from lung cancer patients or cancer cell lines after 10 µM of 
compound 2 for 24 h. Results show the mean value ± SD of at least three independent 
experiments. 
Figure 2. Potent transmembrane anion transport activity of tambjamine analogues in 
liposomes and cellular models. (A) Chloride efflux upon addition of compound 2 or 7 at 
different concentrations to vesicles composed of POPC. (B) Impact of external buffer 
(NaNO3, squared symbols, or NaHCO3/Na2SO4, triangular symbols) in the chloride efflux 
promoted by 2 or 7 (0.1 µM, blue and red symbols, respectively) (See section 2.2. for 
details). Each trace represents an average of at least three different experiments. (C) 
Acridine orange staining on A549 cells treated with vehicle (DMSO), 10 µM compound 2 or 7 
for 1 h. Images are representative of three independent experiments. 
Figure 3. Cytoplasmic vacuolization induced 
by tambjamine analogues. (A) Phase contrast microscopy images of A549 cells treated with 
IC75 of compounds 2 or 7 for 6 h. (B) Time-course photographs of A549 cells treated with 10 
µM of compound 2 or 7 during 24 h. Scale bars 100 µm (A) and 50 µm (B). Images are 
representative of three independent experiments. 
Figure 4. Tambjamine analogues treatment 
did not induce swelling of autophagosomes, lysosomes or early endosomes. 
Immunofluorescence in A549 cells treated with IC75 of compound 2 for 6 h. It was performed 
with different antibodies that recognize several cellular organelles (red) and were compared 
to the distribution of cytoplasmic vacuoles observed by phase contrast microscopy. (A) 
Distribution of the autophagosomal marker LC3, (B) distribution of lysosomal marker LAMP1 
(C) distribution of the early endosome marker EEA1. The nucleus was counterstained with 
TOPRO-3 (blue). Scale bar 20 µm. Images are representative of at least three independent 
experiments.  
Figure 5. Mitochondrial swelling after tambjamine analogues treatment. (A) 
Immunofluorescence of mitochondrial marker TOMM20 in A549 cells treated with IC75 of 
compound 2 for 6 h. The nucleus was counterstained with TOPRO-3 (blue). (B) A549 cells 
overexpressing mCherry-Mito7 plasmid, which targets mitochondria (red), were treated with 
IC75 of compound 2 for 3 h. Mitochondrial staining was compared to vacuolization observed 
in phase contrast photographs. Scale bar 20 µm. (C) Transmission electron micrographs from 
control and treated A549 cells with compound 2 and 7 for 6 h. Mitochondrial swelling (black 
arrows) as well as double-membrane vesicles accumulation (autophagosomes and 
autolysosomes) were observed. Scale bar 2 and 5 µm. Images are representative of at least 
three independent experiments. 
Figure 6. Mitochondrial swelling and loss of mitochondrial membrane potential after 
tambjamine analogues treatment. Confocal images of A549 cells treated with 500 nM 
MitoTracker Red CMXRos during 1 h and then compound 2 for 3 h. Mitochondria with 
normal membrane potential are stained in red. Nucleus was counterstained with DRAQ5 
(blue). Scale bar 20 µm. Images are representative of at least three independent 
experiments. 
Figure 7. p38 MAPK activation, apoptosis induction and autophagy blockade after 
tambjamine analogues treatment. A549 cells were treated with compound 2 IC25, IC50 and 
IC75 values for 24 h and protein extracts were used to determine changes in protein levels. 
Detection and quantification of: (A) the stress kinase p38 MAPK and its phosphorylation 
levels; (B) apoptotic markers such as caspase 9, 3 and PARP substrate and (C) autophagic 
markers like LC3II and p62. Protein levels were normalized with their respective loading 
controls (actin or vinculin) in each blot. Fold changes in protein expression levels were 
quantified and referred to non-treated cells. Data show the mean ± SEM of three 
independent experiments. Statistically significant results are indicated as * p<0.05 and ** 
p<0.01.  
  
Supplementary video legend.  
Cellular swelling and plasmatic membrane breakdown indicative of necrosis after 
tambjamine analogues treatment. A549 cells (1 x 104 cells/well) were seeded in 8-well 
sterile μ-Slide chambered coverslip (Ibidi) and allowed to attach and grow during 72 h. Then 
cells were treated with IC75 of compound 2 and recorded during 6 h. 
